Cardiovascular Complications of Dialysis In Children. Why is this important? Why is this Important? 01/26/2017. Dr Daljit Hothi

Similar documents
HTA ET DIALYSE DR ALAIN GUERIN

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Left ventricular hypertrophy: why does it happen?

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

Structural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak

Dialysis induced cardiac and brain injury

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Hemodialysis: slightly beyond basics Dialysate calcium and magnesium concentrations

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

Heart Failure (HF) Treatment

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

On Referral to our Unit

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012

Cardiorenal Syndrome

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University

Special Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Arterial Pressure in CKD5 - ESRD Population Gérard M. London

Cardiovascular Diseases in CKD

Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis

Hypertension Management Controversies in the Elderly Patient

Advances in Peritoneal Dialysis, Vol. 29, 2013

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007

KDIGO LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE

HEMODIAFILTRATION PRINCIPLES AND ADVANTAGES OVER CONVENTIONAL HD PRESENTATION BY DR.ALI TAYEBI

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

Therefore MAP=CO x TPR = HR x SV x TPR

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

CKD and CVD. Jamal Salameh, MD, FACP, FASN First Coast Nephrology

Definition of Congestive Heart Failure

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Improved Assessment of Aortic Calcification in Japanese Patients Undergoing Maintenance Hemodialysis

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure

Pathophysiology: Heart Failure

Cardiovascular Protection and the RAS

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Therapeutic Targets and Interventions

How to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016

Dialysis in frail and Elderly

Cardiogenic Shock. Carlos Cafri,, MD

M2 TEACHING UNDERSTANDING PHARMACOLOGY

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

LXIV: DRUGS: 4. RAS BLOCKADE

Hypertension and diabetic nephropathy

Calcimimetic agents, vascular calcification prevention 276 Calcium parathyroid hormone regulation Subject Index 357

The Failing Heart in Primary Care

An Investigation Into The Mechanisms, Consequences and Moderators of Intradialytic Hypotension in Paediatric Haemodialysis.

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

Blood Pressure. a change in any of these could cause a corresponding change in blood pressure

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world

THE INTRADIALYTIC BIOFEEDBACKS AND THE CARDIOVASCULAR STABILITY IN HYPOTENSION- PRONE PATIENTS Antonio Santoro, Bologna, Italy

Effects of hemodialysis on cardiac function

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Special Lecture 10/28/2012

Dr Doris M. W Kinuthia

Dialysis: the long case

The right heart: the Cinderella of heart failure

Blood pressure. Formation of the blood pressure: Blood pressure. Formation of the blood pressure 5/1/12

Topic Page: congestive heart failure

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Hemodiafiltration: practical points. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment

Advanced Pathophysiology Unit 5 CV Page 1 of 24. Learning Objectives:

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K.

Strategies to assess and manage hypervolemia The invisible threat in dialysis

Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease

Innovations in Cardio/Renal Patient Care. Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018

DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE

CKD Satellite Symposium

DIASTOLIC HEART FAILURE

Skin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Hypertension in Aortic Valve Disease

Doppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Echocardiography analysis in renal transplant recipients

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

Pathophysiology: Heart Failure. Objectives

Heart Failure Update John Coyle, M.D.

Protecting the heart and kidney: implications from the SHARP trial

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Summary/Key Points Introduction

Coronary artery disease (CAD) risk factors

When should you treat blood pressure in the young?

Pathophysiology of Cardio-Renal Interactions

An Epidemiological Overview

Transcription:

Cardiovascular Complications of Dialysis In Children Dr Daljit Hothi Great Ormond Street Hospital, London Why is this important? 100 90 Why is this Important? Long Term Survival of Childhood Onset ESRD Cardio/cerebrovascular causes 80 70 All causes 60 15 20 25 30 35 40 Age (years) Oh et al. Circulation 2002;106:100 5 1

Why is this Important? Silent Disease Symptoms can be non specific or absent Early manifestations not detected by our standard investigations Pathophysiology still poorly understood Autopsy findings Valvular, Coronary & Pericardial Calcification Atherosclerosis, Medial & Intimal Calcification, Stiff Vessels Microvascular disease Left ventricular hypertrophy Myocardial fibrosis Cardiovascular Risk Factors in CKD Conventional Hypertension Hyperlipidemia Obesity Insulin Resistance Uremia-Related Hyperhomocysteinemia Increased LDL oxidation IV iron induced AOPP Hyperparathyroidism Ca/Ph-Product Dialysis-Related Fluid Overload Infections Bioincompatibility AGE Proinflammatory Cytokine Release Endothelial Dysfunction Systemic Inflammation Acute Phase Response Suppression of Anti-Ca-Precipitants Atherosclerosis / Calcifying Vasculopathy Increased Cardiovascular Mortality 2

Cardiovascular Profiles of Children on Dialysis CKD Stage 5 PD patient HD patient CKD Stage 5 Calcification Coronary & valvular myocardial calcification Intimal and medial calcification Blood pressure Malnutrition Inflammation Complex Syndrome Biological Calcification 3

Coronary Artery Calcification Histological Evidence of Calcification Medial Calcification: IMT, String of Beads Peripheral Arteriopathy Railroad Trucks Medial Calcification Coronary Artery Calcifications in Childhood Onset ESRD 92% Oh et al., Circulation 2002 46% Eifinger et al., NDT 2000 36% Goodman et al., NEJM 2000 15% Civilibal et al., Pediatr Nephrol 2006 10 15 20 25 30 35 40 45 50 Age (years) 4

Predictors of Coronary Artery Calcification in Young Adults with Childhood Onset ESRD Effect Partial R² Total R² P CRP Positive 0.5 0.50 <0.0001 Mean PTH Positive 0.15 0.65 0.0006 Mean (Ca*P)*ESRD Positive 0.07 0.72 0.01 Homocysteine Positive 0.03 0.75 0.05 Oh et al. Circulation 2002;106:100-5 Peripheral Arteriopathy The relative risk of having an increased IMT was 3.7 fold greater in those with high PTH levels than in patients with a PTH within 2x ULM A bimodal distribution is seen with vitamin D associated increase in IMT CKD Stage 5 Calcification Coronary & valvular myocardial calcification Intimal and medial calcification Blood pressure Malnutrition Inflammation Complex Syndrome 5

Blood Pressure & Dialysis What s the best approach for measuring BP in pediatric dialysis patients? Pre, post or interdialytic BP, ABPM, BP load, nocturnal dip, In adults several studies in patients with essential hypertension have described a J shaped curve between DBP and mortality In adult dialysis patients Foley et al 1996 observed that low, not high, BP was associated with increased mortality Systolic BP Post dialysis And Cardio/Cerebrovascular Mortality In Hemodialysis Patients (1992 1996) SBP < 110 mm Hg versus reference 140 149 RR = 2.62,P < 0.01 SBP >180 mmhg versus reference RR = 1.06, P < 0.05 SBP 110 119mm Hg versus reference RR = 1.48, P < 0.01 PG Zager et al. KI 1998 LV Hypertrophy in Children With CKD 4C Study 6

LV Geometry in Children with CKD CKiD Cohort n = 366 IPPN Cohort n = 507 Ischaemia Cardiac remodelleing CKD Stage 5 Calcification Coronary & valvular myocardial calcification Intimal and medial calcification Blood pressure Malnutrition Inflammation Complex Syndrome 7

Malnutrition Inflammation Complex Signature Malnutrition Inflammation Complex Signature CONSEQUENCES Leads to a low body mass index Hypocholesterolemia Hypocreatininemia Hypohomocysteinemia Reverse epidemiology of CVS risks in dialysis patients. CKD Stage 5 Calcification Coronary & valvular myocardial calcification Intimal and medial calcification Blood pressure: ischemia, cardiac remodelling Malnutrition Inflammation Complex Syndrome Myocardial fibrosis Maladaptive arterial tone 8

Myocardial Fibrosis 1943 Rossle: interstitial widening and fibrosis is common in the hearts of patients dying from uremia Severity of fibrosis increases with the stage of CKD time on maintenance HD Potential reversibility: reduction of fibrosis post transplantation Important Players in Myocardial Fibrosis Factors that operate from the initial stages of CKD renin angiotensin aldosterone system oxidative stress excess of cytokines (cardiotrophin 1,transforming growth factor b1) Factors that act preferentially in more advanced stages of CKD hyperphosphatemia excess PTH cardiac calcification ischemia anemia Hypothetical factors cardiotonic steroids cellular senescence anti cardiotropin antibodies relaxin Myocardial Fibrosis CONSEQUENCES Predisposition to re entry type atrial and ventricular arrhythmia?sudden cardiac death Poor LV compliance impacts LV filling With increasing LV volume risk of pulmonary congestion volume depletion may critically lower LV filling pressure Myocardial dysfunction diastolic heart failure primarily the result of cardiac fibrosis prognosis worse in CKD patients with diastolic heart failure compared with systolic heart failure 9

Maladaptive Arteriolar Tone Arterial calcification Endothelial dysfunction Neuro humoral factors Reflected pulse wave reinforces the central (aortic) systolic BP peak at the expense of the usual reinforcement of the diastolic BP, widening the pulse pressure Throughout A Single HD Session We Undertook Non invasive, Continuous Haemodynamic Monitoring Using The Finometer Finger cuff provides continuous pulse wave analysis at the digital artery An arm cuff is wrapped around the same arm as the finger cuff to undertake a Return to flow calibration of finger cuff pressure against brachial readings Wrist device houses software to calculate hemodynamic variables Group trend 150 6 Systolic BP (mmhg) Heart Rate (beats/min) Total Peripheral Resistance (arbituary units) Stroke volume (mls) Cardiac Output (l/min) 100 50 5 4 3 2 1 0 0 0 60 120 180 240 Time on dialysis (mins) Cardiac output more dependent on chronotropic than ionotropic response Whilst the intradialytic BP fell changes in TPR were small 10

Maladaptive Vascular Tone Arterial stiffness and remodelling increases afterload reduced coronary perfusion during diastole Myocardial demand supply mismatch CKD Stage 5 Calcification Coronary & valvular myocardial calcification Intimal and medial calcification Blood pressure: ischemia, cardiac remodelling Malnutrition Inflammation Complex Syndrome Myocardial fibrosis Maladaptive arterial tone Maladaptive cardiovascular response Peritoneal Dialysis PD considered hemodynamically less challenging compared with HD However increasing volume overload with PD vintage N=464 N=851 N=2023 Kramer et al. Kidney Int 2011 11

Peritoneal Dialysis Metabolic insults drive the cardiovascular morbidity Short term hemodynamic responses: Glucose s mulates insulin = cardiac output Intraperitoneal fluid instillation increases preload or pulse wave reflec on = diastolic BP Biocompatible / bicarbonate fluid = baroreflex sensitivity APD causes cooling = TPR, CO & SV Increased endotoxin levels, from gut oedema, intraperitoneal pressure.but less than HD Advanced Glycation End Products (AGEs) 12

Peritoneal Dialysis: Chronic Volume Overload Hemodialysis Hemodialysis is a hemodynamic stress Intradialytic hypotenison Reduced or absent tachycardic response or bradycardia Kaplan Meier Survival Curves with Frequent, Occasional and no IDH Tislér et al 13

Intradialytic Hypotension Ultrafiltration Rate more important that actual volume Movilli E at al, NDT 2007 Myocardial Stunning Myocardial stunning transientpost ischemic myocardial dysfunction with relatively normal blood flow The resultant LV dysfunction is global or discrete to parts of the LV Repeated episodes of ischemia and stunning are cumulative resulting in myocardial functional hibernation non infarcted 14

Fall in cardiac output and global MBF at 15 minutes in the absence of UF Analysis of Regional LV Wall Motion In An Adult Patient during Standard HD Wall motion is measured over each of 100 chords (red lines) around the LV wall Baseline trace shows normal wall motion at rest By 240 min, 3 new regional wall motion abnormalities (RWMAs) have developed during HD 30 min post-hd, 2 RWMAs have resolved and one persists (arrow) Stunned myocardial segments exhibit significantly greater reduction in MBF 15

Ischaemia Reduced blood flow Reversible regional LV dysfunction Myocardial Stunning Patient K, 2 yr old Hyperkinesis RRWM RRWM RRWM Resolution Baseline End of dialysis Recovery 15 mins post HD Time Strain Curve in HD patient at peak stress (end of HD) Reduced peak segmental strain Asynchronous regional LV contraction 16

Factors associated with Regional LV Dysfunction Pearson s Correlation R 2 p value Absolute systolic BP Intradialytic systolic BP change UF (mls/kg) Months on HD 0.26 0.07 p<0.05 0.32 0.10 p<0.05 0.30 0.09 p<0.05 0.05 0.002 p=0.71 Cardiac Reflexes Low pressure stretch receptors in A, V & pulmonary vessels form the cardiopulmonary reflex. sympathetic response activated by cardiac distension from increase venous return Mechanoreceptors within the LV wall respond to an increase in end diastolic pressure reflex bradycardia and vasodilatation (Bezold Jarisch reflex) Baroreflex arc under autonomic control, regulates BP. impaired baroreflex sensitivity (BRS) is an accepted marker of autonomic dysfunction Impact Baroreflex senstivity IDH resistant with impaired BRS exhibit the greatest increase in TPR during HD. A strong correlation between volume and CO at the end of HD in unstable patients with impaired BRS, rendering their CV response to HD highly volume dependent. 17

Treatment Preventative/modulatory CKD MBD Salt and water balance Cardio protective measures Residual renal function PD: biocompatible solutions HD: hemodynamic stability Coronary Calcification Score in Incident Dialysis Patients Block et al. Kidney Int 2005 RIND Trial: Improved Survival of Dialysis Patients by Calcium Free Phosphate Binders Block et al. Kidney Int 2007 18

cimt Covaries with Phosphate Binder Intake and Ca*P Product in Dialyzed Children 5 R=0.41; p<0.05 5 R=0.42; p<0.05 4 4 3 3 IMT SDS 2 1 IMT SDS 2 1 0 0-1 -1-2 -2 10 100 1000 Cumulative phosphate binder dose (g/kg) 2.5 3.0 3.5 4.0 4.5 5.0 5.5 Mean serum Ca*P (mmol²/l²) Litwin et al. JASN 2005; 16:1494 500 Calcimimetic Prevents Vascular Calcifications in Uremic Rats Lopez et al. Kidney Int 2008 Vitamin D Supplementation On Arterial Morphology And Function IMT SDS PWV SDS *<0.008 *<0.0001 3 3 IMT SDS 2 1 PWV SDS 2 1 0 0-1 Vitamin D No Vitamin D -2 Vitamin D No Vitamin D 19

Kaplan Meier survival curves in patients who started PD and were treated or not with ACEi and/or ARBs CARAVACA et al 2014 20

Kaplan Meier survival curves in patients who started HD CARAVACA et al 2014 Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10 Year Cohort Chao Hsiun Tang, JASN 2016 21

Peritoneal Dialysis Diuretic Use May Preserve Urine Output in Children on PD 401 incident patients with retained diuresis at PD initiation Hazard Ratio p Glomerulopathy 4.14 <0.0001 Urine output at PD initiation 0.55 0.009 (L/m 2 /d) Daily ultrafiltration (L/m 2 /d) 1.53 0.003 Dialytic glucose exposure (g/kg/d) 1.27 0.0008 Icodextrin use 2.10 0.008 BMI SDS 1.21 0.06 Diuretic use 0.21 0.008 ACE inhibitor use 1.37 0.14 Ha IS et al. Kidney Int 2015 22

Biocompatible Dialysate Solution Hemodialysis Increased Hemodynamic Stability Cooled Dialysate & Intradialytic Hypotension Beneficial Selby et al 23

Carnitine & Intradialytic hypotension No Real Benefit Lynch et al Hemodialysis Plasma Electrolytes Kovesdy CJASN 2007 Hemodialysis Dialysis Modality 24

Hemodialysis Dialysis Modality Negative correlation between increasing ultrafiltration volumes and decreasing relative risk of mortality in patients on HDF Conclusion Cardiovascular disease is important in paediatrics and modifiable The profile for PD and HD patients is different In PD patient respond our attention should be focused on the metabolic effects of dialysis In HD patients our attention should be focused on improving hemodynamic stability 25